Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about psilocybin therapy

Recent news which mentions psilocybin therapy

Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
Tickers KAYS NEWS
Tags News MDMA Therapy Kaya Holdings
From Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
Tickers NEWS NUMIF
Tags News MDMA Therapy Psychedelics Research
From Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Tickers ATAI CMND CMPS CYBN
Tags Global SPRC Benzinga
From Benzinga
Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients
Tickers NEWS
Tags Cannabis Market News Benzinga
From Benzinga
Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details
Tags News Apex Labs Psychedelics
From Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
Tickers RVVTF
Tags News Markets RVVTF
From Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
Tickers TRUFF
Tags Financing Cannabis Market News
From Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
Tags Markets News Legal
From Benzinga
Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down
Tags News Psychedelics Legalization virginia
From Benzinga
2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change
Tags Markets Cannabis Market News
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
Tickers ATAI AWKNF CMND CMPS
Tags Health Canada TSLA Generalized Anxiety Disorder
From Benzinga
Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect
Tags Markets Cannabis Market News
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Tickers KONEF NMLSF
Tags Benzinga Penny Stocks Cannabis
From Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
Tags Health Canada Special Access Program Benzinga Psychedelic/Assisted Therapies
From Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
Tags Benzinga Market News Diamond Therapeutics Inc/
From Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
Tickers CMPS
Tags Markets News CMPS
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
Tickers CSA DEA
Tags News RTT Legal
From Benzinga
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
Tags News psilocybin therapy Psychedelics
From Benzinga
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
Tags Breast Cancer Therapy Market News Cannabis
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
Tickers CMPS
Tags Benzinga Markets Cannabis
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
Tags Government Regulations News
From Benzinga
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
Tickers RVVTF
Tags Psilocin Pharma Corp Neurological Disorders Addictions
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags Cannabis Market News James Lanthier
From Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
Tickers AWKNF RVLWF
Tags Markets military veterans News
From Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
Tickers ATAI
Tags psilocybin therapy Psychedelics ARK Genomic Revolution EFT
From Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
Tags Psilocybin John Hopkins University psilocybin therapy
From Benzinga
The Case For Psilocybin Therapy And Depression
Tags contributors Benzinga Market News
From Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
Tickers ATAI
Tags Markets PTSD anxiety
From Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms
Tickers CMPS
Tags Cannabis Markets Guy Goodwin
From Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
Tickers ATAI CMPS
Tags Markets David Bronner Regulations
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.